ABPI appoints head of medical affairs from GSK
May 6, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Jacintha Sivarajah, acha
The ABPI has appointed Dr Jacintha Sivarajah as the body’s new head of medical affairs. Reporting directly to its executive …
Lundbeck gains new chief executive from Novo Nordisk
May 6, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kåre Schultz, Lundbeck, Novo Nordisk, Rebien Sorensen
Danish pharma giant Lundbeck has appointed Kåre Schultz as its new president and chief executive. Schultz (pictured) will take up …
Teva forges ahead with Mylan pursuit
May 6, 2015Sales and Marketing Mylan, Perrigo, Teva, generics
Teva has reinforced its commitment to buy Mylan despite previous rejection and only days after Mylan upped its own bid …
GSK files ultra-rare disease application with EMA
May 6, 2015Research and Development, Sales and Marketing EMA, GSK, GSK2696273, Wiskott-Aldrich syndrome, bubble boy, metachromatic leukodystrophy
GlaxoSmithKline has become the first big pharma firm to file for a European marketing authorisation for a gene therapy to …
AbbVie’s Humira meets endpoint in eye disease study
May 6, 2015Research and Development, Sales and Marketing AbbVie, FDA, Humira, Zydus Cadila, adalimumab, uveitis
In a Phase III trial AbbVie’s anti-inflammatory medicine Humira has been shown to significantly lower the risk of uncontrolled uveitis …
New chief business officer for Corium
May 6, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Joseph Sarret, corium
Dr Joseph Sarret has joined commercial-stage US biopharma firm Corium International in the newly-created position of chief business officer.
Chinese government to lift drug price controls
May 5, 2015Sales and Marketing China, Drug pricing, GSK, IMS, Xarelto, government
The Chinese government has announced that it will remove price caps for most medicines and allow the market to play …
Bayer buys blood-thinning drug from Isis
May 5, 2015Research and Development, Sales and Marketing Bayer, Eliquis, ISIS-FXI, Isis, Xarelto, blooding thinning
German drug giant Bayer is sealing a $155 million deal with Isis Pharmaceuticals to gain access to its anti-clotting treatment …
Worldwide cancer spending tops $100 billion
May 5, 2015Research and Development, Sales and Marketing Cancer, IMS Health, keytruda, oncology
Over $100 billion was spent on cancer medicines across the world last year as a new generation of drugs begins …
Novo Nordisk invests in haemophilia with Denmark facility
May 5, 2015Manufacturing and Production, Sales and Marketing Novo Nordisk, diabetes, haemophilia, novoseven
Novo Nordisk is spending around $225 million on a new facility in Kalundborg, Denmark to produce active pharmaceutical ingredients for haemophilia …
Working Life: AstraZeneca’s Jonathan Day
May 5, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Jonathan Day, Working Life
How did you find your way into your current role? By way of background, I trained in medicine at the …
Two consultants join RSA’s UK team
May 5, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Agata Grzeszczuk, Andy Theodorou, rsa
Life sciences recruitment firm RSA has appointed two new consultants to its UK executive search team. Agata Grzeszczuk (pictured) takes …
Takeda pays $2.7 billion to settle Actos lawsuits
May 1, 2015Sales and Marketing Actos, FDA, Takeda, bladder, lilly, pioglitazone, type 2
Takeda has agreed to pay $2.7 billion to finally settle thousands of US lawsuits claiming its diabetes drug Actos can …
Martindale Pharma expands business in Asia-Pacific
May 1, 2015Manufacturing and Production, Sales and Marketing Singapore, aft pharma, martindale
UK-based speciality firm Martindale Pharma is to expand its business in the Asia-Pacific market with the appointment of AFT Pharmaceuticals …
GSK sees FDA clearance for asthma drug
May 1, 2015Sales and Marketing Breo Ellipta, FDA, GSK, Theravance
GlaxoSmithKline and Theravance’s Breo Ellipta inhaler has been approved by the FDA to treat asthma in adults. Whilst the once-daily treatment …
Virgo Consumer Health & Wellbeing hires associate director
May 1, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kirsty McKinnon, Virgo
Virgo Consumer Health & Wellbeing has appointed Kirsty McKinnon to lead the division’s personal care sector. McKinnon joins the firm …
Profits fall at Bayer but new drugs see growth
May 1, 2015Sales and Marketing Bayer, Eliquis, Eylea, Renegeron, Xarelto, apixaban
Bayer’s pharmaceutical revenues have continued their upward trajectory in the first quarter of 2015 thanks to new products, although this …
Apple research apps to require ethics board approval
April 30, 2015Sales and Marketing Apple, BMJ, FDA, GP, researchkit
New guidelines will require apps developed for Apple’s ResearchKit health platform to be approved by an independent ethics board. The …
Perrigo bats away raised Mylan bid
April 30, 2015Sales and Marketing Mylan, Perrigo, Teva, Vigodman, merger
Perrigo has rejected an updated $34.1 billion takeover bid from Mylan, whilst Teva has also written an open letter in …
NHS ‘close to breaking point’
April 30, 2015Medical Communications, Sales and Marketing BMJ, Godlee, Kings Fund, NHS, king's fund
England’s NHS is ‘stretched close to breaking point’ and the next five years are likely to be the most challenging …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
